P60.07 TMB and Selected Mutations in Resectable Stage IIIA NSCLC Patients Receiving Neo-Adjuvant Chemo-Immunotherapy from NADIM Trial
Cruz-Bermudez, A., Casarrubios, M., Briviesca, R. Laza, Nadal, E., Insa, A., Mosquera, J., Huidobro, G., Gómez, M. Dómine, Massuti, B., Tarruella, M. Majem, Rodríguez-Abreu, D., Martinez-Marti, A., De Castro Campeño, J., Dols, M. Cobo, Vivanco, G. López, Del Barco, E., Caro, R. Bernabé, Viñolas, N., Barneto, I., Viteri, S., Jove, M., Romero, A., Franco, F., Provencio, M.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
FP12.09 Molecular Insight into NADIM Clinical Trial: Potential Immune Biomarkers of Pathological Response for NSCLC Patients
Laza Briviesca, R., Nadal, E., Casarrubios, M., Insa, A., Sierra-Rodero, B., Garcia Campelo, M.R., Huidobro, G., Dómine Gómez, M., Massuti, B., Majem, M., Rodríguez-Abreu, D., Martinez-Marti, A., De Castro Campeño, J., Cobo Dols, M., López Vivanco, G., Del Barco, E., Bernabé Caro, R., Viñolas, N., Barneto, I., Viteri, S., Cruz-Bermudez, A., Provencio, M.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article
P60.11 TCR Repertoire Predicts Pathological Response in NSCLC Patients Receiving Neoadjuvant Chemoimmunotherapy from NADIM Trial
Casarrubios, M., Nadal, E., Cruz-Bermudez, A., Insa, A., Briviesca, R. Laza, Campelo, M.R. Garcia, Sierra-Rodero, B., Casal, J., Dómine, M., Massuti, B., Tarruella, M. Majem, Rodríguez-Abreu, D., Martinez-Marti, A., De Castro Campeño, J., Dols, M. Cobo, Vivanco, G. López, Del Barco, E., Caro, R. Bernabé, Viñolas, N., Barneto, I., Viteri, S., Jove, M., Franco, F., Provencio, M.
Published in Journal of thoracic oncology (01.03.2021)
Published in Journal of thoracic oncology (01.03.2021)
Get full text
Journal Article